2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
69
Rectal Neoplasms
10
Triple Negative Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Carcinoma, Intraductal, Noninfiltrating
6
Adenocarcinoma of Lung
6
Breast Carcinoma In Situ
4
Pancreatic Neoplasms
2
Unilateral Breast Neoplasms
1
Transsexualism
1
Solitary Pulmonary Nodule
1
Social Isolation
1
Recurrence
1
Piebaldism
1
Patient Satisfaction
1
Pain, Postoperative
1
Neoplastic Cells, Circulating
1
Neoplasm Micrometastasis
1
Margins of Excision
1
Lymphedema
1
Local Recurrence of Malignant Tumor of Breast
1
Inflammatory Breast Neoplasms
1
Gynecomastia
1
Gastrointestinal Stromal Tumors
1
Colorectal Neoplasms
1
Chordoma
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Interventions
Paclitaxel
11
Carboplatin
8
Radiotherapy
7
Letrozole
7
Cyclophosphamide
7
Trastuzumab
5
Chemotherapy, Adjuvant
5
Doxorubicin
4
Brachytherapy
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
atamestane
3
Toremifene
3
Tamoxifen
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Epirubicin
3
Docetaxel
3
Cryosurgery
3
Cisplatin
3
pertuzumab
2
Surgical Procedures, Operative
2
Radiation
2
Lapatinib
2
Fulvestrant
2
Estrogen Receptor Modulators
2
Cryotherapy
2
Capecitabine
2
Biopsy
2
Aromatase Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Mastectomy, Segmental
×
Clear all
NCT03909282
2026-03-12
NORDIS
Stanford University
Phase NA
Recruiting
50 enrolled